235 related articles for article (PubMed ID: 1558418)
1. The utility of cyclosporine weaning in renal transplantation.
Loertscher R; Blier L; Steinmetz O; Nohr C
Ann Surg; 1992 Apr; 215(4):368-76. PubMed ID: 1558418
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclosporin weaning on glomerular filtration rate in renal transplantation.
Salas M; Loertscher R; Caro JJ
Nephron; 1996; 74(2):309-12. PubMed ID: 8893146
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
Slakey DP; Johnson CP; Callaluce RD; Browne BJ; Zhu YR; Roza AM; Adams MB
Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous quadruple immunosuppression with cyclosporine induction therapy in high risk renal transplant recipients.
Indudhara R; Khauli RB; Menon M; Stoff JS
J Urol; 1994 Aug; 152(2 Pt 1):307-11. PubMed ID: 8015058
[TBL] [Abstract][Full Text] [Related]
5. A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. Italian Multicentre Study Group for Renal Transplantation (SIMTRe).
Ponticelli C; Tarantino A; Segoloni GP; Cambi V; Rizzo G; Altieri P; Mastrangelo F; Castagneto M; Salvadori M; Valente U; Cossu M; Federico S; Pisani F; Montagnino G; Messina M; Arisi L; Carmellini M; Piredda G; Corbetta G
J Am Soc Nephrol; 1997 Apr; 8(4):638-46. PubMed ID: 10495794
[TBL] [Abstract][Full Text] [Related]
6. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
7. Triple therapy in cadaveric renal transplantation: role of induction cyclosporine and targeted levels to avoid rejection.
Khauli RB; Wilson JM; Baker SP; Valliere SA; Lovewell TD; Stoff JS
J Urol; 1995 Jun; 153(6):1805-9; discussion 1810. PubMed ID: 7752322
[TBL] [Abstract][Full Text] [Related]
8. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
[No Abstract] [Full Text] [Related]
9. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
[TBL] [Abstract][Full Text] [Related]
10. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
[TBL] [Abstract][Full Text] [Related]
11. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD
Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219
[TBL] [Abstract][Full Text] [Related]
12. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
14. Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.
Gotti E; Perico N; Perna A; Gaspari F; Cattaneo D; Caruso R; Ferrari S; Stucchi N; Marchetti G; Abbate M; Remuzzi G
J Am Soc Nephrol; 2003 Mar; 14(3):755-66. PubMed ID: 12595513
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
Kahan BD
Lancet; 2000 Jul; 356(9225):194-202. PubMed ID: 10963197
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
17. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK
Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
[TBL] [Abstract][Full Text] [Related]
19. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens.
Lindholm A; Ohlman S; Albrechtsen D; Tufveson G; Persson H; Persson NH
Transplantation; 1993 Aug; 56(2):307-15. PubMed ID: 8356584
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]